Celldex Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2013 | — | -1,981.1% | -1,983.7% |
| FY2014 | — | -3,414.1% | -3,292.8% |
| FY2015 | — | -2,363.9% | -2,321.1% |
| FY2016 | 76.4% | -1,958.7% | -1,894.0% |
| FY2017 | 94.5% | -953.7% | -730.1% |
| FY2018 | 92.7% | -1,640.1% | -1,585.1% |
| FY2019 | 97.2% | -1,540.2% | -1,424.0% |
| FY2020 | 97.3% | -854.1% | -805.9% |
| FY2021 | 97.8% | -1,531.8% | -1,516.0% |
| FY2022 | 95.8% | -4,889.0% | -4,765.6% |
| FY2023 | 95.6% | -2,245.3% | -2,054.8% |
| FY2024 | 97.2% | -2,778.9% | -2,248.8% |
| FY2025 | 87.1% | -18,599.8% | -16,748.0% |